These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 10137013)
1. Serving patient needs while implementing cost effectiveness programs in health care administration. Tootelian DH Health Mark Q; 1994; 11(3-4):161-73. PubMed ID: 10137013 [TBL] [Abstract][Full Text] [Related]
2. Using pharmaceutical cost analyses for decision making. U'Ren NA Hosp Cost Manag Account; 1997 Nov; 9(8):1-7. PubMed ID: 10178832 [No Abstract] [Full Text] [Related]
3. Involving physicians in efforts to control pharmaceutical expenditures. Shulkin DJ; McGourty ME; Bourret J Med Interface; 1995 Aug; 8(8):85-7, 90. PubMed ID: 10144777 [TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services. McGhan WF Hosp Formul; 1993 Apr; 28(4):365-6, 371-3, 377-8. PubMed ID: 10125323 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of therapeutic drug monitoring. Gardner DM; Hardy BG Can J Hosp Pharm; 1990 Feb; 43(1):7-12, xii. PubMed ID: 10113128 [TBL] [Abstract][Full Text] [Related]
7. Pharmacoeconomic factors in the treatment of acute hypertension. Shulkin DJ Hosp Formul; 1994 Aug; 29 Suppl 2():S15-20. PubMed ID: 10135742 [TBL] [Abstract][Full Text] [Related]
8. Antibiotic surveillance: the results of a clinical pharmacy intervention program. Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947 [TBL] [Abstract][Full Text] [Related]
9. Use of randomized controlled trials in organizational decision making: a cost-minimization approach. Cher DJ; Maclure M Am J Manag Care; 2000 Aug; 6(8):894-904. PubMed ID: 11186501 [No Abstract] [Full Text] [Related]
10. Pharmacoeconomics and the formulary decision-making process. Bakst A Hosp Formul; 1995 Jan; 30(1):42-50. PubMed ID: 10172201 [TBL] [Abstract][Full Text] [Related]
11. A cost comparison of Canadian and U.S. hospital pharmacy departments. Weil TP Hosp Pharm; 1994 Jan; 29(1):15-7, 20-3. PubMed ID: 10131492 [TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection. Quenzer RW; Pettit KG; Arnold RJ; Kaniecki DJ Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367 [TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomic principles and methods: an introduction for hospital pharmacists. Sanchez LA Hosp Pharm; 1994 Aug; 29(8):774, 777-9. PubMed ID: 10135744 [No Abstract] [Full Text] [Related]
14. Reducing outpatient costs of nonsteroidal antiinflammatory drugs at a Department of Veterans Affairs teaching hospital. Drexler PG; Lambdin CS J Pharm Technol; 1993; 9(1):10-3. PubMed ID: 10123760 [TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomics: therapeutic and economic considerations in treating the critically ill patient. Crane VS DICP; 1990 Nov; 24(11 Suppl):S24-7. PubMed ID: 2125394 [TBL] [Abstract][Full Text] [Related]
16. Economics & the pharmacy. Souhrada L Hospitals; 1990 Oct; 64(19):52, 54, 56. PubMed ID: 2119336 [TBL] [Abstract][Full Text] [Related]
17. Slowing rate of cost increases in the pharmacy. Roark M Hospitals; 1993 Jan; 67(2):56. PubMed ID: 8419282 [TBL] [Abstract][Full Text] [Related]
18. Philosophical concerns regarding cost-effectiveness analyses. Weiner BK Med Hypotheses; 2010 Feb; 74(2):383-6. PubMed ID: 19651478 [TBL] [Abstract][Full Text] [Related]